Ahmedabad: Torrent Pharmaceuticals Limited (‘’Company”) has announced its financial results for the second quarter of FY 26.
Revenue & profitability:
- Revenue at Rs. 3,302 crores, up by 14% YoY
- Op. EBITDA* at Rs.1,083 crores, up by 15% YoY
- Op. EBITDA margin* at 32.8%; Gross Margin: 76%
- Net Profit after tax at Rs. 591 crores, up by 30% YoY
Performance summary:
| Results | Q2 FY26 | Q2 FY25 | YoY % |
H1 FY26 | H1 FY25 | YoY % |
||||
| Rs cr | % | Rs cr | % | Rs cr | % | Rs cr | % | |||
| Revenues | 3,302 | 2,889 | 14% | 6,480 | 5,748 | 13% | ||||
| Gross profit | 2,502 | 76% | 2,211 | 77% | 13% | 4,906 | 76% | 4,376 | 76% | 12% |
| Op EBITDA* | 1,083 | 33% | 939 | 33% | 15% | 2,115 | 33% | 1,843 | 32% | 15% |
| Exceptional item** | (13) | 0% | 0% | – | (13) | 0% | 0% | – | ||
| PAT | 591 | 18% | 453 | 16% | 30% | 1,139 | 18% | 910 | 16% | 25% |
| R&D spend | 156 | 5% | 145 | 5% | 8% | 313 | 5% | 280 | 5% | 12% |
*Before exceptional items
** Exceptional item comprises regulatory and statutory filing fees paid to acquire controlling stake in J.B. Chemicals & Pharmaceuticals Ltd.
India:
- India revenues at Rs 1,820 crores were up by 12% led by outperformance in focus therapies.
- As per AIOCD secondary market data, IPM growth for the quarter was 8%.
- Torrent’s chronic business grew at 13% vs IPM growth of 11%
- On a MAT basis, Torrent has outperformed the market across focused therapies aided by strong new launch performance. Torrent has 21 brands in the Top 500 brands in IPM, with 15 brands having more than Rs.100 crores sales.
- For H1 FY26, revenues were Rs 3,631 crores, up by 11%.
Brazil:
- Brazil revenues at Rs 318 crores, were up by 21%.
- Constant currency revenues at R$ 196 million, were up by 13%.
- As per IQVIA, Torrent grew at 15% vs market growth of 7%.
- Growth was aided by the performance of top brands & recent launches.
- Torrent has 65 products under ANVISA review.
- For H1 FY26, revenues were Rs 536 crores, up by 17% (Constant currency revenue: R$ 340 million, up by 14%).
United States:
- US business revenues at Rs 337 crores, were up by 26%.
- Constant currency revenues at $39 million, were up by 21% compared to the same period in the previous year. Recent launches have achieved target market shares.
- For H1 FY26, revenues were Rs 646 crores, up by 23% (Constant currency revenue: $75 million up by 18%).
Germany:
- Germany revenues at Rs 303 crores, were up by 5%.
- Constant currency revenues at EUR 30 million, were down by 5%.
- Growth was impacted due to supply disruption at a third party supplier.
- For H1 FY26, revenues were Rs 612 crores, up by 7% (Constant currency revenue: Euro 62 million, down by 2%).
